Handelsbanken Fonder AB Raises Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Handelsbanken Fonder AB boosted its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 9.8% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 15,674 shares of the company’s stock after acquiring an additional 1,400 shares during the period. Handelsbanken Fonder AB’s holdings in Acadia Healthcare were worth $1,219,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Headlands Technologies LLC purchased a new position in shares of Acadia Healthcare in the third quarter valued at $25,000. Fifth Third Bancorp grew its stake in shares of Acadia Healthcare by 25.5% in the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock worth $52,000 after buying an additional 136 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new stake in shares of Acadia Healthcare in the 3rd quarter worth about $96,000. Oak Thistle LLC purchased a new stake in shares of Acadia Healthcare during the 4th quarter valued at about $235,000. Finally, Advisor Partners II LLC lifted its holdings in shares of Acadia Healthcare by 7.5% in the 3rd quarter. Advisor Partners II LLC now owns 3,351 shares of the company’s stock valued at $236,000 after acquiring an additional 234 shares during the last quarter.

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $73.59 on Monday. The stock has a market cap of $6.80 billion, a price-to-earnings ratio of -294.36, a price-to-earnings-growth ratio of 2.17 and a beta of 1.31. The firm has a 50-day moving average of $78.07 and a two-hundred day moving average of $77.74. Acadia Healthcare Company, Inc. has a 1 year low of $66.49 and a 1 year high of $87.77. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.67 and a quick ratio of 0.67.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.80 by $0.05. The company had revenue of $742.80 million for the quarter, compared to analysts’ expectations of $727.60 million. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. During the same quarter in the prior year, the firm earned $0.70 earnings per share. Acadia Healthcare’s revenue was up 10.0% compared to the same quarter last year. On average, research analysts forecast that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current year.

Insider Activity at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now directly owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 2.80% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

ACHC has been the topic of a number of recent research reports. Cantor Fitzgerald restated a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, March 5th. UBS Group boosted their price objective on shares of Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. TD Cowen raised their target price on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. Barclays began coverage on shares of Acadia Healthcare in a report on Wednesday, March 6th. They set an “overweight” rating and a $100.00 price target on the stock. Finally, TheStreet raised shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. Four analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $92.00.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.